Evidence map›Paper›PMID 42612587›Full record

ReviewCurrent opinion in chemical biology2026

Mapping subcellular microenvironments using oligonucleotide-directed proximity labeling.

Scott A Schactler, Nicholas G Skiados, Amol A Gajendragadkar, Lorenzo E DeLeon, David M Shechner

Abstract readReview
In one paragraph

Review in Current opinion in chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Scott A SchactlerDepartment of Pharmacology, University of Washington, Seattle, WA, 98195, USA; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, 98109, USA; Brotman Baty Institute for Precision Medicine, Seattle, WA, 98195, USA.
Nicholas G SkiadosDepartment of Pharmacology, University of Washington, Seattle, WA, 98195, USA; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, 98109, USA; Brotman Baty Institute for Precision Medicine, Seattle, WA, 98195, USA.
Amol A GajendragadkarDepartment of Pharmacology, University of Washington, Seattle, WA, 98195, USA; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, 98109, USA; Brotman Baty Institute for Precision Medicine, Seattle, WA, 98195, USA.
Lorenzo E DeLeonDepartment of Pharmacology, University of Washington, Seattle, WA, 98195, USA; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, 98109, USA; Brotman Baty Institute for Precision Medicine, Seattle, WA, 98195, USA.
David M ShechnerDepartment of Pharmacology, University of Washington, Seattle, WA, 98195, USA; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, 98109, USA; Brotman Baty Institute for Precision Medicine, Seattle, WA, 98195, USA. Electronic address: shechner@uw.edu.

Funding

INTERDISCIPLINARY TRAINING IN GENOMIC SCIENCEST32HG000035 · NHGRI · UNIVERSITY OF WASHINGTON · PI Bruce Colston Trapnell · 1995 to 2026
$24.2M
Function, composition, and mechanism of RNA splicing factories in cardiomyopathyR01HL160825 · NHLBI · UNIVERSITY OF WASHINGTON · PI Charles E Murry · 2023 to 2026
$2.3M
Oligonucleotide-directed in situ proximity biotinylation: a unified method for mapping RNA-interacting proteomes, transcriptomes and genomic loci within intact cells.R01GM138799 · NIGMS · UNIVERSITY OF WASHINGTON · PI SHECHNER, DAVID MICHAEL · 2020 to 2024
$1.7M
Drug Action, Metabolism and Kinetics Training GrantT32GM159560 · NIGMS · UNIVERSITY OF WASHINGTON · PI WILLIAM M ATKINS, Libin Xu · 2025 to 2026
$746k
Molecular characterization of Nuclear Body assembly and pathological misassemblyR21HG014903 · NHGRI · UNIVERSITY OF WASHINGTON · PI Miroslav Dundr, David Michael Shechner · 2026 to 2026
$445k
NHGRI NIH HHS R21 HG014903NHGRI NIH HHS T32 HG000035NHLBI NIH HHS R01 HL160825NIGMS NIH HHS R01 GM138799NIGMS NIH HHS T32 GM159560
6 · The paper itself

Abstract

Understanding how cells compartmentalize their biomolecules into discrete structures remains one of the fundamental goals of cell biology. The proliferation of proximity labeling (PL) technologies has been invaluable toward this goal, enabling biochemical "dissection" of compartments that would be intractable to classical biochemical methods. While robust PL approaches have long been established for targeting proteins of interest, targeting nucleic acids-RNAs and genomic loci-has remained significantly more challenging. Here, we review recent advancements in the field that overcome this longstanding roadblock by using programmable DNA oligonucleotides to direct PL enzyme localization. These tools are already revealing new insights into the molecular architecture of cellular compartments that lie at the heart of gene expression. They also provide a foundation for developing a new generation of PL tools that exploit the modularity and programmability of oligonucleotide-based devices to enable precise spatiotemporal control at previously inaccessible targets and in challenging specimen types.

Indexed as

Cellular MicroenvironmentOligonucleotidesStaining and LabelingAnimalsHumansOligonucleotides

Identifiers

PMID42612587
PMCPMC13536968

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.